← Explore
Enlivex Ltd.
ENLV
$0.01
per share, on-chain
What Enlivex does
Enlivex Ltd. is an Israel-based clinical-stage macrophage reprogramming immunotherapy company focused on developing innovative cell therapies for sepsis, osteoarthritis, and psoriatic arthritis.
- Industry
- Healthcare
- CEO
- Oren Hershkovitz
- Website
- enlivex.com
Ways to own Enlivex Ltd.
There's one version of this stock on Firstshare.
OndoENLVonOur pick
Wider choice. Usually $20 minimum, and it can cost more when New York is closed.
Daily backing report (29 Oct) ↗Monthly backing report (Sep 2026) ↗
$0.01
Closed until New York opens
Price check
What a slice looks like
+1661 1666 whole shares
$10.00 buys you 1666.66 of Enlivex shares.
1666 whole shares plus 65.8% of another. One share costs $0.01.